Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile by Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Julio Santelises, Valeria Vasquez-Saez, Daniel F. Escobar, Daniel Soto, Cecilia Canales, Janepsy Díaz, Liliana Lamperti, Daniela Castillo, Mychel Urra, Felipe Zuñiga, Valeska Ormazabal, Estefanía Nova-Lamperti, Rosana Benítez, Alejandra Rivera, Claudia P. Cortes, Claudia P. Cortes, Claudia P. Cortes, María Teresa Valenzuela, Heriberto E. García-Escorza, Abel E. Vasquez, Abel E. Vasquez, Abel E. Vasquez

Get full text